Cita APA

Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013). Tumorigenicity as a Clinical Hurdle for Pluripotent Stem Cell Therapies.

Citación estilo Chicago

Lee, Andrew S., Chad Tang, Mahendra S. Rao, Irving L. Weissman, y Joseph C. Wu. Tumorigenicity As a Clinical Hurdle for Pluripotent Stem Cell Therapies. 2013.

Cita MLA

Lee, Andrew S., et al. Tumorigenicity As a Clinical Hurdle for Pluripotent Stem Cell Therapies. 2013.